Cargando…
Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2
The novel coronavirus disease 2019 (COVID-19) that emerged in China has spread to more than 212 countries to date. COVID-19 can cause serious acute respiratory syndrome (SARS). Therefore, research advances on the associated SARS-coronavirus-2 (CoV-2) may enable the scientific community to establish...
Autores principales: | Jbeli, Rim, Jelassi, Awatef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254859/ https://www.ncbi.nlm.nih.gov/pubmed/34250222 http://dx.doi.org/10.1007/s41207-021-00263-6 |
Ejemplares similares
-
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022) -
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009) -
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016) -
93. Novel recombinant measles virus vaccine prevents measles virus disease in rhesus macaques
por: Rubens, Jessica, et al.
Publicado: (2022)